Showing results (31-40 of 344) with videos related to

Sort By:
Pageof 35
Journal of Market Access & Health Policy|May 29, 2024
EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity?Volker Schuster
Journal of Market Access & Health Policy|August 24, 2023
Systematic literature reviews over the yearsBeata Smela, Mondher Toumi, Karolina Świerk, et al.
Journal of Market Access & Health Policy|July 13, 2023
The impact of amortization of gene therapies funding on the results and conclusions of CEMs and BIMsHubert Polek, Justyna Janik, Ewelina Paterak, et al.
Journal of Market Access & Health Policy|February 6, 2019
Results and validation of an index to measure health state of patients with depression in automated healthcare databasesFrançois-Xavier Lamy, Bruno Falissard, Clément François, et al.
Journal of Market Access & Health Policy|September 18, 2020
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UKKevin Bowrin, Jean-Baptiste Briere, Pierre Levy, et al.
Journal of Market Access & Health Policy|September 18, 2020
Organizational aspect in healthcare decision-making: a literature reviewAmélie Dubromel, Marie-Audrey Duvinage-Vonesch, Loïc Geffroy, et al.
Journal of Market Access & Health Policy|April 29, 2016
A review of the value of innovation in inhalers for COPD and asthmaJohann Christian Virchow, Cezmi A Akdis, Josep Darba, et al.
Journal of Market Access & Health Policy|April 29, 2016
Current process and future path for health economic assessment of pharmaceuticals in FranceMondher Toumi, Cécile Rémuzat, Emna El Hammi, et al.
Journal of Market Access & Health Policy|April 29, 2016
Market access pathways for cell therapies in FranceCécile Rémuzat, Mondher Toumi, Jesper Jørgensen, et al.
Pageof 35